Back to index
IDRx

IDRx

idrx.comBiopharmaceuticals

What AI says about IDRx

GSK aims to positively impact the health of 2.5 billion people by the end of the decade, focusing on four key therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. They leverage cutting-edge technologies like single-cell genomics and artificial intelligence to transform drug discovery and treatment.

Is this your brand?

Claim this profile to keep your information accurate and add what's missing.

Not in this profile yet:

Company details

Products & Services

Respiratory Health

Innovative therapies targeting respiratory diseases, including COPD.

Oncology

Advanced treatments aimed at combating various forms of cancer.

HIV Treatments

Long-acting therapies and innovative solutions for individuals living with HIV.

Infectious Disease Solutions

Therapeutics focused on preventing and treating infectious diseases.

Common Questions

What therapeutic areas does GSK focus on?

GSK focuses on respiratory health, immunology and inflammation, oncology, HIV, and infectious diseases.

How does GSK aim to impact global health?

GSK aims to positively impact the health of 2.5 billion people by the end of the decade through innovative therapies and responsible pricing.

What technologies does GSK use in drug discovery?

GSK employs single-cell and spatial genomics along with artificial intelligence to enhance drug discovery.

Company Information

Employees
1000+
Industries
BiopharmaHealthcarePharmaceuticals